المؤلفون: Pua A; Mane SEA Pte Ltd, 3 Biopolis Drive, #07-17/18/19 Synapse, Singapore 138623, Singapore.; Department of Food Science and Technology, National University of Singapore, S14 Level 5, Science Drive 2, Singapore 117542, Singapore., Huang Y; Mane SEA Pte Ltd, 3 Biopolis Drive, #07-17/18/19 Synapse, Singapore 138623, Singapore.; Department of Food Science and Technology, National University of Singapore, S14 Level 5, Science Drive 2, Singapore 117542, Singapore., Vivian Goh RM; Mane SEA Pte Ltd, 3 Biopolis Drive, #07-17/18/19 Synapse, Singapore 138623, Singapore., Ee KH; Mane SEA Pte Ltd, 3 Biopolis Drive, #07-17/18/19 Synapse, Singapore 138623, Singapore., Li L; Department of Food Science and Technology, National University of Singapore, S14 Level 5, Science Drive 2, Singapore 117542, Singapore., Cornuz M; Mane SEA Pte Ltd, 3 Biopolis Drive, #07-17/18/19 Synapse, Singapore 138623, Singapore., Lassabliere B; Mane SEA Pte Ltd, 3 Biopolis Drive, #07-17/18/19 Synapse, Singapore 138623, Singapore., Jublot L; Mane SEA Pte Ltd, 3 Biopolis Drive, #07-17/18/19 Synapse, Singapore 138623, Singapore., Liu SQ; Department of Food Science and Technology, National University of Singapore, S14 Level 5, Science Drive 2, Singapore 117542, Singapore., Yu B; Mane SEA Pte Ltd, 3 Biopolis Drive, #07-17/18/19 Synapse, Singapore 138623, Singapore.

المصدر: Journal of agricultural and food chemistry [J Agric Food Chem] 2023 Mar 15; Vol. 71 (10), pp. 4337-4345. Date of Electronic Publication: 2023 Mar 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 0374755 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-5118 (Electronic) Linking ISSN: 00218561 NLM ISO Abbreviation: J Agric Food Chem Subsets: MEDLINE

مواضيع طبية MeSH: Coffee*/chemistry , Odorants*/analysis, Gas Chromatography-Mass Spectrometry/methods ; Chromatography, Gas/methods

المؤلفون: Ngoi NY; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore., Syn NL; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore.; Department of Surgery, University Surgical Cluster, National University Health System, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Goh RM; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore., Goh BC; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore., Huang RY; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore., Soon YY; Department of Radiation Oncology, National University Cancer Institute, Singapore, Singapore., James E; Medical Research Council Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK., Cook A; Medical Research Council Clinical Trials Unit, Institute of Clinical Trials and Methodology, University College London, London, UK., Clamp A; Department of Medical Oncology, The Christie NHS Foundation Trust and University of Manchester, Manchester, UK., Tan DS; Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore.; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.

المصدر: The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2022 Feb 21; Vol. 2. Cochrane AN: CD012007. Date of Electronic Publication: 2022 Feb 21.

نوع المنشور: Journal Article; Meta-Analysis; Review; Systematic Review

بيانات الدورية: Publisher: Wiley Country of Publication: England NLM ID: 100909747 Publication Model: Electronic Cited Medium: Internet ISSN: 1469-493X (Electronic) Linking ISSN: 13616137 NLM ISO Abbreviation: Cochrane Database Syst Rev Subsets: MEDLINE

مواضيع طبية MeSH: Ovarian Neoplasms*/surgery , Paclitaxel*/adverse effects, Bevacizumab/therapeutic use ; Carboplatin/adverse effects ; Carcinoma, Ovarian Epithelial/drug therapy ; Carcinoma, Ovarian Epithelial/surgery ; Female ; Humans

المؤلفون: Chong WQ; Department of Haematology-Oncology, National University Cancer Institute, Singapore., Lim CM; Department of Otolaryngology - Head and Neck Surgery, National University of Singapore, Singapore., Sinha AK; Department of Diagnostic Imaging, National University Health System, Singapore., Tan CS; Department of Haematology-Oncology, National University Cancer Institute, Singapore., Chan GHJ; Department of Haematology-Oncology, National University Cancer Institute, Singapore., Huang Y; Department of Haematology-Oncology, National University Cancer Institute, Singapore., Kumarakulasinghe NB; Department of Haematology-Oncology, National University Cancer Institute, Singapore., Sundar R; Department of Haematology-Oncology, National University Cancer Institute, Singapore., Jeyasekharan AD; Department of Haematology-Oncology, National University Cancer Institute, Singapore.; Cancer Science Institute of Singapore, NUS, Singapore., Loh WS; Department of Otolaryngology - Head and Neck Surgery, National University of Singapore, Singapore., Tay JK; Department of Otolaryngology - Head and Neck Surgery, National University of Singapore, Singapore., Yadav K; Cancer Science Institute of Singapore, NUS, Singapore., Wang L; Cancer Science Institute of Singapore, NUS, Singapore.; Department of Pharmacology, National University of Singapore, Singapore., Wong AL; Department of Haematology-Oncology, National University Cancer Institute, Singapore.; Cancer Science Institute of Singapore, NUS, Singapore., Kong LR; Cancer Science Institute of Singapore, NUS, Singapore., Soo RA; Department of Haematology-Oncology, National University Cancer Institute, Singapore.; Cancer Science Institute of Singapore, NUS, Singapore., Lau JA; Cancer Science Institute of Singapore, NUS, Singapore., Soon YY; Department of Radiation Oncology, National University Cancer Institute, Singapore., Goh RM; Department of Haematology-Oncology, National University Cancer Institute, Singapore., Ho FCH; Department of Radiation Oncology, National University Cancer Institute, Singapore., Chong SM; Department of Pathology, National University of Singapore, Singapore., Lee SC; Department of Haematology-Oncology, National University Cancer Institute, Singapore.; Cancer Science Institute of Singapore, NUS, Singapore., Loh KS; Department of Otolaryngology - Head and Neck Surgery, National University of Singapore, Singapore., Tai BC; School of Public Health, National University of Singapore, Singapore., Lim YC; Department of Pathology, National University of Singapore, Singapore.; Department of Physiology, National University of Singapore, Singapore., Goh BC; Department of Haematology-Oncology, National University Cancer Institute, Singapore. phcgbc@nus.edu.sg.; Cancer Science Institute of Singapore, NUS, Singapore.; Department of Pharmacology, National University of Singapore, Singapore.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Oct 15; Vol. 26 (20), pp. 5320-5328. Date of Electronic Publication: 2020 Aug 14.

نوع المنشور: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Cisplatin/*administration & dosage , Deoxycytidine/*analogs & derivatives , Nasopharyngeal Carcinoma/*drug therapy , Neovascularization, Pathologic/*drug therapy, Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Cisplatin/adverse effects ; Deoxycytidine/administration & dosage ; Deoxycytidine/adverse effects ; Disease-Free Survival ; Female ; Fluorouracil/administration & dosage ; Humans ; Male ; Middle Aged ; Nasopharyngeal Carcinoma/pathology ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/pathology ; Neovascularization, Pathologic/pathology ; Sunitinib/administration & dosage ; Gemcitabine

المؤلفون: Kong LR; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore. csiklr@nus.edu.sg.; Medical Research Council Cancer Unit, University of Cambridge, Cambridge, CB2 0XZ, UK. csiklr@nus.edu.sg., Mohamed Salleh NAB; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore., Ong RW; Laboratory of Molecular Endocrinology, National Cancer Centre Singapore, Singapore, 169610, Singapore., Tan TZ; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore., Syn NL; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore.; Department of Hematology-Oncology, National University Cancer Institute, Singapore, 119074, Singapore., Goh RM; Department of Hematology-Oncology, National University Cancer Institute, Singapore, 119074, Singapore., Fhu CW; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore., Tan DSW; Cancer Therapeutics Research Laboratory, National Cancer Centre Singapore, Singapore, 169610, Singapore.; Division of Medical Oncology, National Cancer Centre Singapore, Singapore, 169610, Singapore.; Genome Institute of Singapore, Agency for Science, Technology & Research (A*STAR), Singapore, 138672, Singapore., Iyer NG; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore.; Office of Clinical Sciences, Duke-NUS Medical School, Singapore, 169857, Singapore.; Division of Surgical Oncology, National Cancer Centre Singapore, Singapore, 169610, Singapore., Kannan S; Bioinformatics Institute, Agency for Science, Technology, and Research (A*STAR), Singapore, 138671, Singapore., Verma CS; Bioinformatics Institute, Agency for Science, Technology, and Research (A*STAR), Singapore, 138671, Singapore.; Department of Biological Sciences, National University of Singapore, Singapore, 119228, Singapore.; School of Biological Sciences, Nanyang Technological University, Singapore, 639798, Singapore., Lim YC; Department of Pathology, National University Health System, Singapore, 119074, Singapore., Soo R; Department of Hematology-Oncology, National University Cancer Institute, Singapore, 119074, Singapore., Ho J; Department of Hematology-Oncology, National University Cancer Institute, Singapore, 119074, Singapore., Huang Y; Department of Hematology-Oncology, National University Cancer Institute, Singapore, 119074, Singapore., Lim JSJ; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore.; Department of Hematology-Oncology, National University Cancer Institute, Singapore, 119074, Singapore., Yan BJ; Department of Pathology, National University Health System, Singapore, 119074, Singapore., Nga ME; Department of Pathology, National University Health System, Singapore, 119074, Singapore., Lim SG; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119228, Singapore.; Division of Gastroenterology and Hepatology, National University Health System, Singapore, 119074, Singapore., Koeffler HP; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore.; Department of Hematology-Oncology, National University Cancer Institute, Singapore, 119074, Singapore.; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119228, Singapore.; Department of Hematology and Oncology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA., Lee SC; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore.; Department of Hematology-Oncology, National University Cancer Institute, Singapore, 119074, Singapore., Kappei D; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore., Hung HT; Laboratory of Molecular Endocrinology, National Cancer Centre Singapore, Singapore, 169610, Singapore., Goh BC; Cancer Science Institute of Singapore, National University of Singapore, Singapore, 117599, Singapore. phcgbc@nus.edu.sg.; Department of Hematology-Oncology, National University Cancer Institute, Singapore, 119074, Singapore. phcgbc@nus.edu.sg.; Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 119228, Singapore. phcgbc@nus.edu.sg.

المصدر: Nature communications [Nat Commun] 2020 Mar 25; Vol. 11 (1), pp. 1556. Date of Electronic Publication: 2020 Mar 25.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Squamous Cell/*genetics , Carcinoma, Squamous Cell/*pathology , Proto-Oncogene Proteins c-met/*genetics , Proto-Oncogene Proteins c-met/*metabolism , Receptor, ErbB-2/*metabolism, Animals ; Antineoplastic Agents/pharmacology ; Antineoplastic Agents/therapeutic use ; Carcinoma, Squamous Cell/drug therapy ; Carcinoma, Squamous Cell/mortality ; Cell Line, Tumor ; Head and Neck Neoplasms/drug therapy ; Head and Neck Neoplasms/genetics ; Head and Neck Neoplasms/mortality ; Head and Neck Neoplasms/pathology ; Humans ; Lung Neoplasms/drug therapy ; Lung Neoplasms/genetics ; Lung Neoplasms/mortality ; Lung Neoplasms/pathology ; Mice ; Mutation ; Phenotype ; Phosphorylation/drug effects ; Polymorphism, Genetic ; Prognosis ; Protein Binding ; Protein Interaction Domains and Motifs ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Proto-Oncogene Proteins c-met/chemistry ; Receptor, ErbB-2/antagonists & inhibitors ; Signal Transduction/drug effects ; Xenograft Model Antitumor Assays